Editorial introductions
Dedicator of cytokinesis 8 (DOCK8) deficiency
Newborn screening for T-cell deficiency
Common variable immunodeficiency at the end of a prospering decade: towards novel gene defects and beyond
Immunodeficiency secondary to anticytokine autoantibodies
Chronic mucocutaneous candidiasis and congenital susceptibility to Candida
Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiency
The impact of molecular biology on allergen immunotherapy
Functional regulatory T cells and allergen immunotherapy
Prophylactic mRNA vaccination against allergy
The current state of recombinant allergens for immunotherapy
Epicutaneous/transcutaneous allergen-specific immunotherapy: rationale and clinical trials
An update on immunotherapy for food allergy
Regulatory aspects of specific immunotherapy in Europe
Current World Literature